Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Notes Payables (2020 - 2025)

Stemtech (STEK) has disclosed Notes Payables for 6 consecutive years, with $2.4 million as the latest value for Q3 2025.

  • Quarterly Notes Payables changed N/A to $2.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Sep 2025, changed N/A year-over-year, with the annual reading at $2.0 million for FY2024, 60.05% up from the prior year.
  • Notes Payables hit $2.4 million in Q3 2025 for Stemtech, down from $2.4 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $2.4 million in Q2 2025 to a low of $446246.0 in Q4 2022.
  • Historically, Notes Payables has averaged $1.5 million across 5 years, with a median of $1.5 million in 2022.
  • Biggest five-year swings in Notes Payables: surged 1194.64% in 2021 and later crashed 54.38% in 2023.
  • Year by year, Notes Payables stood at $453123.0 in 2021, then dropped by 1.52% to $446246.0 in 2022, then soared by 186.46% to $1.3 million in 2023, then soared by 60.05% to $2.0 million in 2024, then rose by 15.41% to $2.4 million in 2025.
  • Business Quant data shows Notes Payables for STEK at $2.4 million in Q3 2025, $2.4 million in Q2 2025, and $2.4 million in Q1 2025.